Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03678870 · ClinicalTrials.gov registry record · NA
Discharge Opioid Education to Decrease Opioid Use After Cesarean
A NA study of Opioid Use, sponsored by Vanderbilt University Medical Center.
- Completed
- Registry status
- NA
- Development phase
- 196
- Enrollment target
- 1
- Study location
NCT03678870: Completed NA study of Opioid Use, sponsored by Vanderbilt University Medical Center.
NCT03678870 is a NA study of Opioid Use that has completed, run by Vanderbilt University Medical Center. The registered enrollment target is 196 participants, below the 148,258-participant average among 105 other Opioid Use trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03678870, a NA study of Opioid Use, has completed, sponsored by Vanderbilt University Medical Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 196 participants
- Enrollment target
- 1
- Study location
Study Summary
Background: The number of opioid overdose deaths in the United States has quadrupled in 15 years, a dramatic manifestation of the current opioid abuse epidemic. This rise parallels a sharp increase in the amount of legal prescription opioids dispensed. The abundance of prescription opioids available is a primary pathway for opioid abuse and diversion and higher opioid use after surgery has been associated with an increased risk of chronic opioid use. Reducing the amount of opioid used after cesarean delivery may decrease the risk of chronic opioid use and will help towards better estimating and reducing the amount of opioids prescribed at discharge. Objective: To to compare discharge opioid education to standard care to ascertain whether opioid education reduces opioid use after hospital discharge
Primary Outcome
Median number of tablets of hydrocodone-acetaminophen used after hospital discharge
Conditions Studied
Interventions
- OTHER Opioid Education Handout
Study Locations (1)
Tennessee
- Sarah Osmundson - Nashville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 196 participants |
| Start Date | 2018-09-01 |
| Est. Completion | 2019-11-01 |
| Phase | NA |
What the finished NCT03678870 record still lists
NCT03678870 is an interventional study that assigns participants to a tested intervention. The registered 196 participants enrollment target is mid-sized for trials with a published cap, below the 148,258-participant average among 105 other Opioid Use trials with a reported enrollment target (100% lower).
The record links to 1 condition, with Opioid Use appearing as the primary indexed condition, and to 1 intervention - of which Opioid Education Handout is the first listed.
NCT03678870 reports a single indexed study location in Tennessee.
Frequently Asked Questions
What is clinical trial NCT03678870 about?
NCT03678870 is a clinical study titled "Discharge Opioid Education to Decrease Opioid Use After Cesarean". Background: The number of opioid overdose deaths in the United States has quadrupled in 15 years, a dramatic manifestation of the current opioid abuse epidemic. This rise parallels a sharp increase in the amount of legal prescription opioids dispensed. The abundance of prescription opioids available...
What is the current status of trial NCT03678870?
This trial is currently completed. It is a NA study. The enrollment target is 196 participants. The study started on 2018-09-01. Estimated completion is 2019-11-01.
What conditions does trial NCT03678870 study?
This clinical trial studies the following conditions: Opioid Use.
What interventions are being tested in trial NCT03678870?
The interventions under investigation include: Opioid Education Handout (OTHER).
Who is sponsoring clinical trial NCT03678870?
This trial is sponsored by Vanderbilt University Medical Center, which has 677 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03678870 being conducted?
This trial has 1 study location across Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Opioid Use
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03678870's enrollment target sits among peer trials
196 40th of 105 higher than 66 of 105 other Opioid Use trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Opioid Use trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
QL vs LAI for Palatoplasty
RECRUITING · NA
-
Machine-Learning Prediction and Reducing Overdoses With EHR Nudges
RECRUITING · NA
-
Hip Arthroscopy Postoperative Opioid Demands
RECRUITING · NA
-
Neuroimaging of Opioid Phase (OPAL)
RECRUITING · NA
-
Encouraging Abstinence Behavior in a Drug Epidemic: Optimizing Dynamic Incentives
RECRUITING · NA
-
Opioid Prescribing Practices in Laparoscopic Gynecologic Surgery
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02822768 · 196 participants · NA
Packing Versus no Packing for Cutaneous Abscess
- NCT04250259 · 196 participants · Phase 2
SAMe Trial for Patients With Alcoholic Cirrhosis
- NCT05142592 · 196 participants · Phase 1
Phase1/2a Study for IPG7236 in Patients With Advanced Solid Tumors
- NCT05317832 · 196 participants · Phase 2
Using Smartphones to Improve Physical Activity Levels of Individuals With Spinal Cord Injury
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI